pepti

Search PeptiGuide

Popular searches

Thyreogen

At a glance

PeptiGuide dataset · reviewed Aug 2026

What it is

Thyroid-focused bioregulator supplement with preclinical evidence only.

Status

Preclinical

Typical dose

10–20mg

Researched for

Thyroid function, metabolism, thyroid health

Trial progress

  1. PrePreclinical
  2. IPhase I
  3. IIPhase II
  4. IIIPhase III
  5. IVPhase IV
  6. FDAFDA approved

Preclinical - Promising animal research, limited human data

Stay current

Get updates on Thyreogen

New studies, regulatory decisions and data corrections - delivered when they land.

  • Thyreogen is described as a cytomax thyroid bioregulator supplement made from short calf-thyroid peptides.
  • The source does not provide a defined amino-acid sequence.
  • It is listed as not FDA approved, with evidence status.
  • Source-reported use areas include thyroid function, metabolism, and thyroid health.
  • Product-specific clinical evidence is limited, and claims remain unproven.

Thyreogen is described under the Khavinson bioregulator framework. In that model, short tissue-derived peptides are hypothesized to enter cells and influence gene-expression programs, potentially through DNA-associated effects. The source reports thyroid-focused vendor claims involving thyroid-cell metabolism and T3, T4, and calcitonin output, but it also states that a Thyreogen-specific receptor, pathway, or independently established mechanism has not been mapped.

Where the research stands

The source places Thyreogen within the broader Khavinson bioregulator literature, which includes Russian publications and review-level discussions of short peptides as possible epigenetic regulators. It also states that evidence directly testing Thyreogen as a specific product is sparse, with no registered randomized placebo-controlled human trials for thyroid disease identified in the source material. Reported animal or family-level endocrine and geroprotective findings should therefore be treated as hypothesis-generating rather than proof for Thyreogen itself.

What it shows

Animal studies

Promising animal research, limited human data

Limitations

Animal study doses may not translate directly to humans.

Bottom line: Preclinical research; approved in Russia as a supplement Not FDA approved

Typical dosing

Community

10–20 mg

daily

10 mg20 mg

Community-reported dosing for a thyroid bioregulator; source notes possible thyroid hormone effects and limited safety evidence.

Research dosing

Animal studies only

Doses observed in studies

10-20 mg daily

Animal study doses may not translate directly to humans.

Duration
10-30 day cycles
Administration
Oral capsules or sublingual

Best time to take

Morning on an empty stomach

Once or twice daily

Food recommendation

Take on an empty stomach

Why this timing?

The source says peptide bioregulators are commonly timed away from food because fasted use is presented as supporting absorption.

Not everyone experiences these. Individual responses vary with dose, duration, and personal factors.

  • Generally well tolerated
  • May affect thyroid hormone levels
  • Limited safety data outside Russia
  • Not FDA approved

Not everyone experiences side effects, and severity can vary by context, purity, route, and individual health factors.

One open dataset

Every fact on this page - doses, side effects, references - comes from the same PeptiGuide dataset that powers the Tracker, Compare, and the Lab.

Browse the dataset

Educational resource, not medical advice. Talk to your clinician before acting on anything here.

Community discussion

Comments are moderated before they appear. Keep it evidence-focused.